GlassScriptPhysician profile
Donald Skor
NPI 1831116391
$1,316.14
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $533 · 2020: $338 · 2021: $445.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $735.92 | 2019-2021 | |
| Astellas Pharma US INC | $159.14 | 2019-2021 | |
| Lilly USA, LLC | $71.27 | 2019-2021 | |
| Allergan, INC. | $61.09 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.06 | 2020-2021 | |
| Amgen INC. | $32.98 | 2021 | |
| Novo Nordisk INC | $31.22 | 2021 | |
| Sanofi-Aventis U.S. LLC | $29.86 | 2021 | |
| Antares Pharma, INC. | $27.76 | 2020-2021 | |
| Abbott Laboratories | $21.23 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $20.82 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $16.96 | 2021 | |
| Lifescan, INC. | $16.88 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $15.86 | 2021 | |
| Amarin Pharma, INC. | $14.31 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $13.12 | 2021 | |
| Merck Sharp & Dohme LLC | $12.66 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Skor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.